- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeted therapy in lymphoma ; volume:3 ; number:1 ; day:23 ; month:11 ; year:2010 ; pages:1-10 ; date:12.2010
Journal of hematology & oncology ; 3, Heft 1 (23.11.2010), 1-10, 12.2010
- Urheber
-
Johnston, Patrick B.
Yuan, RuiRong
Cavalli, Franco
Witzig, Thomas E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-8722-3-45
- URN
-
urn:nbn:de:101:1-2021082020565801076729
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Johnston, Patrick B.
- Yuan, RuiRong
- Cavalli, Franco
- Witzig, Thomas E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Altered pathways and targeted therapy in double hit lymphoma
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Targeted cancer therapy
Bone-Targeted Therapy
Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
Targeted Therapy beim Nierenzellkarzinom
Targeted Therapy for CML
Advances in targeted cancer therapy
Targeted therapy in gastric cancer
Altered pathways and targeted therapy in double hit lymphoma
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Targeted cancer therapy
Bone-Targeted Therapy
Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
Targeted Therapy beim Nierenzellkarzinom
Targeted Therapy for CML
Advances in targeted cancer therapy
Targeted therapy in gastric cancer
Altered pathways and targeted therapy in double hit lymphoma
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma
Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma
Targeted cancer therapy
Bone-Targeted Therapy
Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
Targeted Therapy beim Nierenzellkarzinom
Targeted Therapy for CML
Advances in targeted cancer therapy